No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acute Disease
-
Adolescent
-
Adult
-
Aged
-
Aged, 80 and over
-
Alleles
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Chemokine CXCL12 / genetics*
-
Chemokine CXCL12 / physiology
-
Disease-Free Survival
-
Female
-
Genotype
-
Humans
-
Leukemia, Myeloid / drug therapy
-
Leukemia, Myeloid / genetics*
-
Leukemia, Myeloid / mortality
-
Leukemia, Myeloid / pathology
-
Male
-
Middle Aged
-
Neoplasm Proteins / genetics*
-
Neoplasm Proteins / physiology
-
Polymorphism, Single Nucleotide*
-
Proportional Hazards Models
-
Receptors, CXCR4 / physiology
-
Remission Induction
-
Sarcoma, Myeloid / drug therapy
-
Sarcoma, Myeloid / genetics*
-
Sarcoma, Myeloid / pathology
-
Survival Analysis
Substances
-
CXCL12 protein, human
-
CXCR4 protein, human
-
Chemokine CXCL12
-
Neoplasm Proteins
-
Receptors, CXCR4